CG Oncology, Inc. (CGON)
Biological Products, (No Diagnostic Substances)
Latest Price
$71.19
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
12.92
P/B Ratio
5.51
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 6.98M | $472.0M | 7.94% | +4.97M | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 6.72M | $454.0M | 7.64% | +6.68M | 2026-03-31 |
| Decheng Capital LLC | 6.37M | $431.0M | 7.24% | -- | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 5.37M | $363.0M | 6.10% | -628.6K | 2026-03-31 |
| BlackRock, Inc. | 5.06M | $342.0M | 5.75% | +220.9K | 2026-03-31 |
| FMR LLC | 3.76M | $254.0M | 4.28% | -533.3K | 2026-03-31 |
| TCG Crossover Management, LLC | 3.67M | $248.0M | 4.17% | -- | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.65M | $247.0M | 4.15% | +209.8K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.10M | $209.0M | 3.52% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.03M | $205.0M | 3.45% | -- | 2026-03-31 |